Clinical Trials Browser

Phase 3 × Interventional × abivertinib × Clear all

NCT03856697 2019-02-27

Abivertinib Maleate Versus Geifitinib in Patients With Advanced Non-small Cell Lung Cancer With Sensitive EGFR Mutation

Phase 3 Unknown

Advanced Non-small Cell Lung Cancer